» Articles » PMID: 39948225

Feasibility and Safety of Biologic OviTex Mesh in Ventral Mesh Rectopexy: a Prospective Pilot Study

Overview
Date 2025 Feb 13
PMID 39948225
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Minimal-invasive ventral mesh rectopexy (VMR) is a widely accepted treatment for patients suffering from rectal prolapse. The type of mesh used in VMR remains a subject of debate. Currently, the most applied implant is a polypropylene mesh. The aim of the present pilot study was to determine the ease of use, feasibility, and safety of OviTex PGA mesh, a biologic mesh, in VMR.

Methods: Consecutive patients who underwent VMR for internal or external rectal prolapse were included in a prospective non-randomised pilot study in two centers. Preoperative and postoperative evaluation (90 days and 6 months) with a clinical examination and questionnaire regarding pelvic floor symptoms was performed. The primary objectives were to monitor the perioperative technical end result and the postoperative complication rate.

Results: Sixteen patients underwent VMR with an OviTex PGA implant. All operations were completed successfully and without intraoperative complications. The mean ODS and FISI score was significantly decreased after 6-months follow-up. No graft-related complications (GRC) occurred. Two patients developed a recurrent prolapse within 6 months.

Conclusion: Robotic correction of rectal prolapse using an OviTex mesh is a safe, minimally invasive, technically feasible treatment. However, further research is warranted to evaluate the potential added value of OviTex compared to polypropylene mesh on a larger scale. Long-term follow-up is essential to assess the durability of the procedure and monitor the occurrence of any new symptoms.

References
1.
DHoore A, Cadoni R, Penninckx F . Long-term outcome of laparoscopic ventral rectopexy for total rectal prolapse. Br J Surg. 2004; 91(11):1500-5. DOI: 10.1002/bjs.4779. View

2.
Makela-Kaikkonen J, Rautio T, Paakko E, Biancari F, Ohtonen P, Makela J . Robot-assisted vs laparoscopic ventral rectopexy for external or internal rectal prolapse and enterocele: a randomized controlled trial. Colorectal Dis. 2016; 18(10):1010-1015. DOI: 10.1111/codi.13309. View

3.
Fu C, Stevenson A . Risk Factors for Recurrence After Laparoscopic Ventral Rectopexy. Dis Colon Rectum. 2017; 60(2):178-186. DOI: 10.1097/DCR.0000000000000710. View

4.
Mehmood R, Parker J, Bhuvimanian L, Qasem E, Mohammed A, Zeeshan M . Short-term outcome of laparoscopic versus robotic ventral mesh rectopexy for full-thickness rectal prolapse. Is robotic superior?. Int J Colorectal Dis. 2014; 29(9):1113-8. DOI: 10.1007/s00384-014-1937-4. View

5.
DeNoto 3rd G, Ceppa E, Pacella S, Sawyer M, Slayden G, Takata M . A Prospective, Single Arm, Multi-Center Study Evaluating the Clinical Outcomes of Ventral Hernias Treated with OviTex 1S Permanent Reinforced Tissue Matrix: The BRAVO Study 12-Month Analysis. J Clin Med. 2021; 10(21). PMC: 8584945. DOI: 10.3390/jcm10214998. View